Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH) Mitigates Guanine Nucleotide Dysregulation in rd10 Mice
Author Affiliations & Notes
  • Paul Yang
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Alexander Hurt
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Luke Fraley
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Catherine W Morgans
    Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, Oregon, United States
  • Mark E Pennesi
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Robert Duvoisin
    Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, Oregon, United States
  • Footnotes
    Commercial Relationships   Paul Yang 4D Molecular Therapeutics, Code C (Consultant/Contractor), Adverum, Code C (Consultant/Contractor), BlueRock Therapeutics, Code C (Consultant/Contractor), Eluminex Biosciences, Code C (Consultant/Contractor), Foundation Fighting Blindness, Code C (Consultant/Contractor), Janssen, Code C (Consultant/Contractor), MieraGTx, Code C (Consultant/Contractor), Nanoscope Therapeutics, Code C (Consultant/Contractor); Alexander Hurt None; Luke Fraley None; Catherine Morgans None; Mark Pennesi None; Robert Duvoisin None
  • Footnotes
    Support  Foundation Fighting Blindness TRAP1 Award TA-NMT-0521-0803-OHSU-TRAP (Columbia, MD) (PY). Medical Research Foundation: New Investigator Grant (PY). This work was supported by the National Institutes of Health (Bethesda, MD) P30 EY010572 core grant, the Malcolm M. Marquis, MD Endowed Fund for Innovation, and an unrestricted grant from Research to Prevent Blindness (New York, NY) to Casey Eye Institute, Oregon Health & Science University.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1465. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul Yang, Alexander Hurt, Luke Fraley, Catherine W Morgans, Mark E Pennesi, Robert Duvoisin; Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH) Mitigates Guanine Nucleotide Dysregulation in rd10 Mice. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1465.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : cGMP-dependent cytotoxicity is part of a common photoreceptor cell death pathway in multiple models of inherited retinal degenerations, including the prototypical rd10 model of retinitis pigmentosa. Mycophenolate mofetil (MMF) is a reference inhibitor of IMPDH, a key enzyme for the biosynthesis of guanine nucleotide precursors to cGMP. We previously showed that MMF confers potent neuroprotection in rd10 mice. This study aims to elucidate the neuroprotective mechanisms of MMF by quantifying retinal guanine nucleotides longitudinally.

Methods : rd10 mice received intraperitoneal injections of MMF 100 mg/kg daily postnatal day (P)12-22. After dark-adaptation, whole retina was harvested and flash frozen in liquid nitrogen under dim red light from c57 wildtype, naïve rd10, and MMF-treated rd10 mice every 1-2 days, P10-22. Supernatant from homogenized (0.1 M HCl on ice) and centrifuged tissue samples were used to quantify GMP, GDP, GTP, and cGMP using a 4000 QTRAP hybrid/triple quadrupole linear ion trap mass spectrometer (AB Sciex) with electrospray ionization (ESI) in positive mode, interfaced to a SIL-20AC XR auto-sampler followed by 2LC-20AD XR LC pumps (Shimadzu).

Results : The levels of all guanine nucleotides from rd10 mice were significantly abnormal at multiple time points P10-22. Prior to the onset of structural degeneration (P16), rd10 retina exhibited 1) significantly elevated levels of GMP and GDP at P10-15 with an additional relative GMP spike at P13 (p<0.05 for all), 2) loss of a normal GTP spike at P13 that was observed in c57 mice (p<0.05), and 3) significantly depressed levels of cGMP at P12-15 (P<0.05 for all) except at P14 where there was a relative cGMP spike. After the onset of degeneration, GMP and GDP levels continued to be elevated until P17-19, and cGMP levels were continually depressed to P22 (p<0.05 for all). Treatment with MMF suppressed the relative spikes in GMP at P13 (p<0.05) and cGMP at P14 (p<0.05), and normalized levels of GDP at P13-19 (p<0.05 for all).

Conclusions : Our data support a new concept that dysregulation of all guanine nucleotides is associated with the photoreceptor cell death pathway in rd10 mice. Moreover, MMF normalized GDP levels and mitigated abnormal spikes in GMP and cGMP levels, supporting our hypothesis that the neuroprotective effect of MMF is via the inhibition of IMPDH and guanine nucleotide biosynthesis.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×